1. Home
  2. VLY vs IOVA Comparison

VLY vs IOVA Comparison

Compare VLY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

N/A

Current Price

$14.14

Market Cap

7.8B

Sector

Finance

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.39

Market Cap

6.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLY
IOVA
Founded
1927
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
6.7B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
VLY
IOVA
Price
$14.14
$8.39
Analyst Decision
Buy
Buy
Analyst Count
14
9
Target Price
★ $16.89
$14.40
AVG Volume (30 Days)
6.8M
★ 12.3M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 3.08%
N/A
EPS Growth
★ 46.38
14.84
EPS
★ 0.57
N/A
Revenue
N/A
N/A
Revenue This Year
$12.61
$56.63
Revenue Next Year
$20.48
$43.83
P/E Ratio
$25.01
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.34
$1.76
52 Week High
$15.20
$15.37

Technical Indicators

Market Signals
Indicator
VLY
IOVA
Relative Strength Index (RSI) 66.03 29.97
Support Level $13.32 $7.85
Resistance Level $15.00 $9.36
Average True Range (ATR) 0.31 0.98
MACD 0.19 -0.75
Stochastic Oscillator 88.26 1.76

Price Performance

Historical Comparison
VLY
IOVA

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: